Good find! This paper you linked shows that the strongest methylation differences in the CRH promoter are in a CREB-binding region, which is consistent this review I also posted earlier in the thread:
https://www.sciencedirect.com/science/article/pii/S0091302211000707) There are still a lot of unknowns about CRH regulation, but the review makes a pretty good case that the minimum necessary components for CRH production are cAMP/TORC activation and CREB phosphorylation.
So two possibilities for how epigenetic repression of CRH happens in narcolepsy:
1) the same (likely immune-related) signals in narcolepsy that block orexin production also lead to repression of CREB-binding regions in CRH neurons, or
2) CREB signaling in CRH neurons is dependent on regular stimulation by orexin from orexin-producing neurons. Since CREB phosphorylation is triggered by tons of other stimuli besides orexin, this option seems unlikely though technically possible.
Either way, there’s no evidence that narcolepsy-level orexin depletion is a feature of ME/CFS, so that does help narrow down potential options because we can assume that CREB
should be getting phosphorylated at least daily by orexin signaling.
So in order to end up with the same CRH depletion as in narcolepsy but not orexin depletion, the mystery abnormality in ME/CFS would have to be something that either blocks phosphorylated CREB or blocks cAMP/TORC,
without affecting ETS1 in orexin neurons.